Welcome!

News Feed Item

China Interventional Cardiology Market Outlook to 2020

NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Interventional Cardiology Market Outlook to 2020

http://www.reportlinker.com/p02127373/China-Interventional-Cardiology-Market-Outlook-to-2020.html

China Interventional Cardiology Market Outlook to 2020

Summary

GlobalData's new report, "China Interventional Cardiology Market Outlook to 2020", provides key market data on the China Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Interventional Cardiology categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the China Interventional Cardiology market.
- Key players covered include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc. and Cordis Corporation.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Interventional Cardiology Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Interventional Cardiology Market, China 10
3.1 Interventional Cardiology Market, China, Revenue ($m), 2005-2012 10
3.2 Interventional Cardiology Market, China, Revenue ($m), 2012-2020 12
3.2.1 Arteriotomy Closure Devices Market, China, Revenue ($m), by Segment, 2005-2012 14
3.2.2 Cardiac Catheters Market, China, Revenue ($m), by Segment, 2005-2012 16
3.2.3 Coronary Stents Market, China, Revenue ($m), by Segment, 2005-2012 18
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2005-2012 20
3.2.5 PTCA Balloons Market, China, Revenue ($m), by Segment, 2005-2012 22
3.2.6 Arteriotomy Closure Devices Market, China, Revenue ($m), by Segment, 2012-2020 24
3.2.7 Cardiac Catheters Market, China, Revenue ($m), by Segment, 2012-2020 26
3.2.8 Coronary Stents Market, China, Revenue ($m), by Segment, 2012-2020 28
3.2.9 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2012-2020 30
3.2.10 PTCA Balloons Market, China, Revenue ($m), by Segment, 2012-2020 32
3.3 Interventional Cardiology Market, China, Volume (Units), 2005-2012 34
3.4 Interventional Cardiology Market, China, Volume (Units), 2012-2020 36
3.4.1 Arteriotomy Closure Devices Market, China, Volume (Units), by Segment, 2005-2012 38
3.4.2 Cardiac Catheters Market, China, Volume (Units), by Segment, 2005-2012 40
3.4.3 Coronary Stents Market, China, Volume (Units), by Segment, 2005-2012 42
3.4.4 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2005-2012 44
3.4.5 PTCA Balloons Market, China, Volume (Units), by Segment, 2005-2012 46
3.4.6 Arteriotomy Closure Devices Market, China, Volume (Units), by Segment, 2012-2020 48
3.4.7 Cardiac Catheters Market, China, Volume (Units), by Segment, 2012-2020 50
3.4.8 Coronary Stents Market, China, Volume (Units), by Segment, 2012-2020 52
3.4.9 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2012-2020 54
3.4.10 PTCA Balloons Market, China, Volume (Units), by Segment, 2012-2020 56
3.5 Interventional Cardiology Market, China, Average Price ($), 2005-2020 58
3.6 Interventional Cardiology Market, China, Distribution Share by Revenue ($m), 2011-2012 60
3.7 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2011-2012 61
4 Overview of Key Companies in China, Interventional Cardiology Market 63
4.1 Lepu Medical Technology (Beijing) Co., Ltd. 63
4.1.1 Company Overview 63
4.2 Terumo Corporation 63
4.2.1 Company Overview 63
4.3 Biosensors International Group, Ltd. 63
4.3.1 Company Overview 63
4.4 Abbott Laboratories 64
4.4.1 Company Overview 64
4.5 Boston Scientific Corporation 64
4.5.1 Company Overview 64
4.6 Medtronic, Inc. 64
4.6.1 Company Overview 64
4.7 Asahi Intecc Co., Ltd. 65
4.7.1 Company Overview 65
4.8 Volcano Corporation 65
4.8.1 Company Overview 65
4.9 Cordis Corporation 65
4.9.1 Company Overview 65
5 Interventional Cardiology Market Pipeline Products 66
6 Financial Deals Landscape 67
6.1 Partnerships 67
6.1.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 67
6.1.2 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 68
7 Appendix 69
7.1 Research Methodology 70
7.1.1 Coverage 70
7.1.2 Secondary Research 70
7.1.3 Primary Research 71
7.1.4 Market Modeling and Forecasting 72
7.1.5 Company Share Analysis 75
7.1.6 Distribution Share Analysis 76
7.2 Expert Panel 76
7.3 GlobalData Consulting 77
7.4 Contact Us 77
7.5 Disclaimer 77


1.1
List of Tables


Table 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 11
Table 2: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Table 3: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 15
Table 4: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 5: Coronary Stents Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 19
Table 6: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 21
Table 7: PTCA Balloons Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 23
Table 8: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 25
Table 9: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 27
Table 10: Coronary Stents Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 29
Table 11: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 31
Table 12: PTCA Balloons Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 33
Table 13: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 35
Table 14: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 37
Table 15: Arteriotomy Closure Devices Market, China, Volume (Units), Historic, 2005-2012 39
Table 16: Cardiac Catheters Market, China, Volume (Units), Historic, 2005-2012 41
Table 17: Coronary Stents Market, China, Volume (Units), Historic, 2005-2012 43
Table 18: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Historic, 2005-2012 45
Table 19: PTCA Balloons Market, China, Volume (Units), Historic, 2005-2012 47
Table 20: Arteriotomy Closure Devices Market, China, Volume (Units), Forecast, 2012-2020 49
Table 21: Cardiac Catheters Market, China, Volume (Units), Forecast, 2012-2020 51
Table 22: Coronary Stents Market, China, Volume (Units), Forecast, 2012-2020 53
Table 23: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Forecast, 2012-2020 55
Table 24: PTCA Balloons Market, China, Volume (Units), Forecast, 2012-2020 57
Table 25: Interventional Cardiology Market, China, Average Price ($), Historic, 2005-2012 58
Table 26: Interventional Cardiology Market, China, Average Price ($), Forecast, 2012-2020 59
Table 27: Interventional Cardiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 60
Table 28: Interventional Cardiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 62
Table 29: Interventional Cardiology Market Pipeline Products 66
Table 30: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 67
Table 31: Coherex Medical Enters Into Distribution Agreement With Biosense Webster 68
Table 32: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 72


1.2
List of Figures


Figure 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 10
Figure 2: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 12
Figure 3: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 14
Figure 4: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 5: Coronary Stents Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 18
Figure 6: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 20
Figure 7: PTCA Balloons Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 22
Figure 8: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 24
Figure 9: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 26
Figure 10: Coronary Stents Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 28
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Figure 12: PTCA Balloons Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 32
Figure 13: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 34
Figure 14: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 36
Figure 15: Arteriotomy Closure Devices Market, China, Volume (Units), Historic, 2005-2012 38
Figure 16: Cardiac Catheters Market, China, Volume (Units), Historic, 2005-2012 40
Figure 17: Coronary Stents Market, China, Volume (Units), Historic, 2005-2012 42
Figure 18: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Historic, 2005-2012 44
Figure 19: PTCA Balloons Market, China, Volume (Units), Historic, 2005-2012 46
Figure 20: Arteriotomy Closure Devices Market, China, Volume (Units), Forecast, 2012-2020 48
Figure 21: Cardiac Catheters Market, China, Volume (Units), Forecast, 2012-2020 50
Figure 22: Coronary Stents Market, China, Volume (Units), Forecast, 2012-2020 52
Figure 23: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Forecast, 2012-2020 54
Figure 24: PTCA Balloons Market, China, Volume (Units), Forecast, 2012-2020 56
Figure 25: Interventional Cardiology Market, China, Company Share (%), 2012 61
Figure 26: GlobalData Epidemiology-Based Forecasting Model 74
Figure 27: GlobalData Capital Equipment-Based Forecasting Model 75
Figure 28: Primary Interviews by Participant Type (%) 76


To order this report: China Interventional Cardiology Market Outlook to 2020
http://www.reportlinker.com/p02127373/China-Interventional-Cardiology-Market-Outlook-to-2020.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Everyone wants to use containers, but monitoring containers is hard. New ephemeral architecture introduces new challenges in how monitoring tools need to monitor and visualize containers, so your team can make sense of everything. In his session at @DevOpsSummit, David Gildeh, co-founder and CEO of Outlyer, will go through the challenges and show there is light at the end of the tunnel if you use the right tools and understand what you need to be monitoring to successfully use containers in your...
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
In recent years, containers have taken the world by storm. Companies of all sizes and industries have realized the massive benefits of containers, such as unprecedented mobility, higher hardware utilization, and increased flexibility and agility; however, many containers today are non-persistent. Containers without persistence miss out on many benefits, and in many cases simply pass the responsibility of persistence onto other infrastructure, adding additional complexity.
@DevOpsSummit at Cloud taking place June 6-8, 2017, at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developm...
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the USA and Europe, we work with a variety of customers from emerging startups to Fortune 1000 companies.
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across supply chain networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost and time for product recall as well as advance trade. Are you curious about Blockchain and how it can provide you with new opportunities for innovation and growth? In her session at 20th Cloud Exp...
Cybersecurity is a critical component of software development in many industries including medical devices. However, code is not always written to be robust or secure from the unknown or the unexpected. This gap can make medical devices susceptible to cybersecurity attacks ranging from compromised personal health information to life-sustaining treatment. In his session at @ThingsExpo, Clark Fortney, Software Engineer at Battelle, will discuss how programming oversight using key methods can incre...
Cloud Expo, Inc. has announced today that Aruna Ravichandran, vice president of DevOps Product and Solutions Marketing at CA Technologies, has been named co-conference chair of DevOps at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deli...
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
Did you know that you can develop for mainframes in Java? Or that the testing and deployment can be automated across mobile to mainframe? In his session at @DevOpsSummit at 20th Cloud Expo, Vaughn Marshall, Sr. Principal Product Owner at CA Technologies, will discuss and demo how increasingly teams are developing with agile methodologies using modern development environments and automating testing and deployments, mobile to mainframe.
SYS-CON Events announced today that Grape Up will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company specializing in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the U.S. and Europe, Grape Up works with a variety of customers from emergi...
Translating agile methodology into real-world best practices within the modern software factory has driven widespread DevOps adoption, yet much work remains to expand workflows and tooling across the enterprise. As models evolve from pockets of experimentation into wholescale organizational reinvention, practitioners find themselves challenged to incorporate the culture and architecture necessary to support DevOps at scale. In his session at @DevOpsSummit at 20th Cloud Expo, Anand Akela, Senior...